Biotherapeutics

Talecris Biotherapeutics Helps Patients Receive Gamunex(R) During Lapses in Private Insurance CoverageRESEARCH TRIANGLE PARK, N.C.NC-TALECRIS-BIOTHERA  

Gamunex Connexions Certificate Program Offers Benefits for Patients with Primary Immunodeficiency or Idiopathic Thrombocytopenic Purpura RESEARCH TRIANGLE PARK, N.C.-- --Under a new program introduced by ...  

The National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, has asked Integrated BioTherapeutics Inc. to develop a vaccine that protects against Ebola and Marburg viruses.  

LONDON (Thomson Financial) - Northwest Biotherapeutics Inc. said it has secured a $1.0 million debt financing, which will be sufficient to fund its cash ...  

MELBOURNE, Oct 13 (Reuters) - Australia's CSL Ltd , the world's top plasma products group, said on Monday the U.S. Federal Trade Commission had asked it for more information on its proposed $3.1 billion takeover of smaller U.S. rival Talecris Biotherapeutics.  

Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/GTC+Biotherapeutics+%28GTCB%29+Announces+FDA+Accepts+ATryn%28R%29+BLA+Filing/4044510.html for the full story.  

The US Food and Drug Administration has approved Talecris Biotherapeutics' Gamunex as a treatment for chronic inflammatory demyelinating polyneuropathy .  

Oxygen Biotherapeutics, Inc. today announced that company chairman and CEO Chris J. Stern, DBA will present at the Rodman & Renshaw Annual Global Investment Conference in New York on November 12, 2008 at 12:25 ...  

Vaccine Has Potential to Save Millions of Lives GERMANTOWN, Md., Oct. 7 /PRNewswire/ -- Integrated BioTherapeutics Inc.  

RDATE:26082008 Stocks in the News: Oxygen Biotherapeutics, Inc. , Isolagen, Inc.  

The US Food and Drug Administration, or FDA, has accepted for review GTC Biotherapeutics, Inc.